Collins Cynthia - Insider Non-Derivative Transactions at Poseida Therapeutics, Inc. (PSTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 17, 2024, Collins Cynthia's relationship to Poseida Therapeutics, Inc. (PSTX) is Director, and currently has 58,950 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PSTX insiders.
Data Source: SEC.
Collins Cynthia - Insider Non-Derivative Transactions of PSTX Common Stock
Collins Cynthia - Insider Non-Derivative Transactions at PSTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 18, 2024 | Acquisition -- (Common Stock) | 19650 | 0 | 58950 |
| Jun 16, 2023 | Acquisition -- (Common Stock) | 19650 | 0 | 39300 |